The medical devices maker expects full-year earnings to land near the bottom end of forecast range, and has written down the ...
Cochlear has reported a weaker first-half result, with delays in contracting and price negotiations for its new Nexa implant ...
Cochlear's HY26 saw profit decline and steady dividends, as Nexa implant rollout supports second-half growth plans. The post ...
Explore Cochlear's strategies for managing revenue and margins as it prepares to release its HY 2026 earnings.
LONE TREE, Colo., Jan. 8, 2026 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, is proud to announce that the groundbreaking Nucleus® Nexa® System is now available to ...
The Nucleus 8 Sound Processor is the world's first cochlear implant sound processor ready for Bluetooth LE Audio technology Experience the full interactive ...
When we hear sounds, specialized cells in the cochlear nucleus are the first to process that information, enabling our brains to understand speech, enjoy music and recognize various noises. For ...
Engaging the brain’s plasticity by stimulating the locus coeruleus, a region in the brainstem, could be a clinically relevant approach to optimize the efficacy of cochlear implants in restoring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results